These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36050862)

  • 21. Technology insight: measuring prolactin in clinical samples.
    Smith TP; Kavanagh L; Healy ML; McKenna TJ
    Nat Clin Pract Endocrinol Metab; 2007 Mar; 3(3):279-89. PubMed ID: 17315036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers.
    Hattori N; Ishihara T; Saiki Y
    Clin Endocrinol (Oxf); 2009 Nov; 71(5):702-8. PubMed ID: 19486017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevalence of macroprolactinemia among 115 patients with hyperprolactinemia].
    Vilar L; Moura E; Canadas V; Gusmão A; Campos R; Leal E; Teixeira L; Santos V; Gomes B; Lima M; Paiva R; Albuquerque JL; Egito CS; Botelho CA; Azevedo M; Casulari LA; Naves LA
    Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):86-91. PubMed ID: 17435860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.
    Smith TP; Suliman AM; Fahie-Wilson MN; McKenna TJ
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5410-5. PubMed ID: 12466327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Laboratory and clinical significance of macroprolactinemia in women with hyperprolactinemia.
    Kasum M; Orešković S; Čehić E; Šunj M; Lila A; Ejubović E
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):719-724. PubMed ID: 29241908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishment of reference intervals of monomeric prolactin to identify macroprolactinemia in Chinese patients with increased total prolactin.
    Hu Y; Ni J; Zhang B; Cheng W; Zhang H; Ye H; Ji L; Lu B; Guan M
    BMC Endocr Disord; 2021 Oct; 21(1):197. PubMed ID: 34620143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Hypothyroidism with Exceptionally High Prolactin-A Really Big Deal.
    Khorassanizadeh R; Sundaresh V; Levine SN
    World Neurosurg; 2016 Jul; 91():675.e11-4. PubMed ID: 27155380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of Macroprolactinemia in People Detected to Have Hyperprolactinemia.
    Sharma LK; Dutta D; Sharma N; Kulshreshtha B; Lal S; Sethi R
    J Lab Physicians; 2021 Dec; 13(4):353-357. PubMed ID: 34975255
    [No Abstract]   [Full Text] [Related]  

  • 29. Global Prevalence of Macroprolactinemia among Patients with Hyperprolactinemia: A Systematic Review and Meta-Analysis.
    Che Soh NAA; Yaacob NM; Omar J; Mohammed Jelani A; Shafii N; Tuan Ismail TS; Wan Azman WN; Ghazali AK
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33171973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macroprolactinemia in hyperprolactinemic infertile women.
    Thirunavakkarasu K; Dutta P; Sridhar S; Dhaliwal L; Prashad GR; Gainder S; Sachdeva N; Bhansali A
    Endocrine; 2013 Dec; 44(3):750-5. PubMed ID: 23543432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Macroprolactin detection: a new approach].
    Sapin R; Gasser F; Fischbach E; Grucker D
    Ann Biol Clin (Paris); 2000; 58(6):729-34. PubMed ID: 11098170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Importance of screening for macroprolactin in all hyperprolactinaemic sera.
    Jamaluddin FA; Sthaneshwar P; Hussein Z; Othman N; Chan SP
    Malays J Pathol; 2013 Jun; 35(1):59-63. PubMed ID: 23817395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of monomeric prolactin level by TRACE method and precipitation with polyethylene glycol.
    Vorotnikova SY; Dzeranova LK; Fedorova NS; Pigarova EA; Vershinina MG; Il'in AV
    Klin Lab Diagn; 2021 Mar; 66(2):69-74. PubMed ID: 33734638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macroprolactinemia: diagnostic, clinical, and pathogenic significance.
    Shimatsu A; Hattori N
    Clin Dev Immunol; 2012; 2012():167132. PubMed ID: 23304187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macroprolactin; a frequent cause of misdiagnosed hyperprolactinemia in clinical practice.
    Richa V; Rahul G; Sarika A
    J Reprod Infertil; 2010 Oct; 11(3):161-7. PubMed ID: 23926484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pituitary response profile following metoclopramide administration in women with different forms of hyperprolactinemia.
    Espinós JJ; Vanrell C; Gich I; Urgell E; Calaf J
    Gynecol Endocrinol; 2017 Feb; 33(2):148-151. PubMed ID: 27841032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative adjustment for macroprolactin is an integral part of laboratory assessment of hyperprolactinaemia.
    Heald AH; Blantern E; Anderson SG; Radford D; Qureshi Z; Nair S; Waldron J; Davies M; McCulloch A; Kane J
    Exp Clin Endocrinol Diabetes; 2012 Jun; 120(6):376-80. PubMed ID: 22576261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Macroprolactinemia in a patient with infertility and hyperprolactinemia.
    Khandwala HM
    South Med J; 2006 Nov; 99(11):1282-4. PubMed ID: 17195425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Macroprolactinemia. Risk of misdiagnosis and mismanagement in hyperprolactinemia].
    Valdemarsson S
    Lakartidningen; 2004 Feb; 101(6):458-65. PubMed ID: 15004940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency of Macroprolactin in Hyperprolactinemia.
    Sherazi NA; Baig MZ; Khan AH
    J Coll Physicians Surg Pak; 2018 Feb; 28(2):93-97. PubMed ID: 29394965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.